Affiliation:
1. Ministry of Health and Medical Education
2. Tehran University of Medical Sciences
3. Iran University of Medical Sciences
Abstract
Abstract
Objective: Based on the International Agency for Research on Cancer (IARC), the prevalence and incidence of cervical cancer is increasing globally, especially in low and middle-income countries. Hence, developing a policy brief for meaningful formulation and successful implementation for prevention and control of cancer programs can guide policymakers.
Methods: This policy brief drew from a Ph.D. thesis on policy analysis of cervical cancer prevention in Iran. In this qualitative study, first a systematic review was conducted to compare the economic impact of combined strategies versus testing alone for cervical cancer screening worldwide. Next, a qualitative analysis of cervical cancer prevention and early detection was accomplished from July 2020 to September 2021, in Iran. Finally, to achieve the most important challenges, some solutions were recommended following the participants’ statements and review study.
Results: Compared with cytology-based screening tests or Visual Inspection with Acetic Acid, Human papillomavirus infection testing, alone or combined with other tests, has been reported as a cost-effective cervical cancer screening strategy worldwide, especially in high-income settings. In Iran, the low coverage of cervical cancer screening; inadequate knowledge, awareness and education on cervical cancer, and the economic problems of implementing new cervical cancer prevention strategies were all identified as the main challenges in Iran.
Conclusions: It is recommended to improve the purchasing power for vaccine procurement programs through coordinated action across global partners, i.e., Word Health Organization, Global Alliance for Vaccines and Immunization (Gavi), the Global Fund to Fight Aids, TB & Malaria, the Union for International Cancer Control, and the World Bank, in addition to collaboration with the private sector manufacturers of vaccines, diagnostics, and treatment equipment. Moreover, using educational models of health promotion can be helpful to increase public knowledge and awareness on cervical cancer prevention.
Publisher
Research Square Platform LLC
Reference25 articles.
1. WHO. Global Health Observatory data repository, By category, Noncommunicable diseases,Mortality, Risk of premature death from the four target NCDs, Data by country, Global Health Observatory visualizations, Cervical cancer screening. [Internet]. Geneva: WHO. ; 2016 [updated 2019. Available from: http://apps.who.int/gho/data/node.wrapper.imr?x-id=3354.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global Cancer S, WHO. 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. as part of IARC’s Global Cancer Observatory. [Internet]. 2018 [cited March 21, 2019]. Available from: http://gco.iarc.fr/.
3. Self-sampling for human papillomavirus (HPV) testing: A systematic review and meta-Analysis;Yeh PT;BMJ global health,2019
4. Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis;Sawaya GF;JAMA Intern Med,2019
5. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening;Bidus MA;Obstet Gynecol,2006